During the most recent trading day, the stock’s price shifted up + 8.02 percent from its 52-week-low while -70.96 percent lower from its 52-week high.
Valeant Pharmaceuticals Intl Inc generated a return on investment of -1.60 % in past 12 months and return on equity of -52.70 % for similar period.
The share price of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) declined -58.70 percent for the year. YTD, the current share price of the stock is below -23.00 percent. A company has revealed that it will be taking space in a new building at Mercia Marina near Willington – bringing more than 100 jobs to the area.
Bionical, which works in the pharmaceutical and healthcare industries, already has its global headquarters in a building called The Boardwalk at Findern Lane
But now the company has said it will be expanding into a new £2.5 million building called The Piazza, which is under construction.
At present, Bionical, which first took space at the marina in 2014, has 36 staff based there. But the firm has agreed to take part of the ground floor and all three upper floors of The Piazza, which is being built next to The Boardwalk and is due to be completed by the end of the year. Source: Derby Telegraph
Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) gained 4.68% to $11.18 on Wednesday. The share price is trading in a range of 10.67 – 11.43 (Price in Dollars). The stock exchanged hands with 26,946,962 shares contrast to its average daily volume of 18,950,229 shares.